Literature DB >> 33963917

Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation.

Fidan A Aghayeva1,2, Panagiotis Chronopoulos1, Alexander K Schuster1, Norbert Pfeiffer1, Esther M Hoffmann3.   

Abstract

PURPOSE: This study assesses short-term intraocular pressure (IOP) change in the fellow eye of glaucoma patients after mitomycin C-augmented trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation in the treated eye.
MATERIALS AND METHODS: Retrospective chart review of 235 glaucoma patients (235 eyes) was performed. Patients underwent initial trabeculectomy (187 patients), filtering canaloplasty (25 patients), or PreserFlo™ microshunt implantation (23 patients) in one eye, while the fellow eye was naïve to any previous glaucoma surgery. IOP was evaluated before and on the 1st and 2nd days and at 1 week after surgery. Main outcome measure was IOP change in the fellow eye. Secondary outcomes were proportion of clinically significant IOP elevation in the fellow eye and evaluation of potential risk factors associated with postoperative IOP fluctuation.
RESULTS: IOP in the fellow eye at 1 week after trabeculectomy was statistically significantly lower than preoperatively (p < 0.0001), while the IOP did not change significantly in the fellow eyes in filtering canaloplasty or PreserFlo groups. The higher the preoperative IOP was in the fellow eye, the larger was the intraocular pressure-lowering effect at 1 week after trabeculectomy (p < 0.0001). A clinically significant IOP elevation was noted in 14.2%, 9.5%, and 5% of fellow eyes after trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation, respectively.
CONCLUSIONS: This study shows an IOP-lowering effect in the fellow eye of glaucoma patients after trabeculectomy. Significant IOP rise might occur in the fellow eye of some glaucoma patients after different types of glaucoma surgery.

Entities:  

Keywords:  Fellow eye; Filtering canaloplasty; Glaucoma surgery; Intraocular pressure; PreserFlo™ microshunt; Trabeculectomy

Year:  2021        PMID: 33963917     DOI: 10.1007/s00417-021-05188-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  26 in total

1.  Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study.

Authors:  J Piltz; R Gross; D H Shin; J A Beiser; D A Dorr; M A Kass; M O Gordon
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  On changes in intraocular pressure after application of the tonometer; in the same eye and in the other eye.

Authors:  F W STOCKER
Journal:  Am J Ophthalmol       Date:  1958-02       Impact factor: 5.258

3.  On the ophthalmotonic consensual reaction and its relationship to aqueous humor dynamics.

Authors:  E L PRIJOT; H H STONE
Journal:  Am J Ophthalmol       Date:  1956-07       Impact factor: 5.258

4.  The consensual ophthalmotonic reaction.

Authors:  M V Gibbens
Journal:  Br J Ophthalmol       Date:  1988-10       Impact factor: 4.638

5.  The uniocular therapeutic trial in the management of elevated intraocular pressure.

Authors:  S M Drance
Journal:  Surv Ophthalmol       Date:  1980 Nov-Dec       Impact factor: 6.048

6.  The contralateral reduction of intraocular pressure by timolol.

Authors:  C N Dunham; R F Spaide; G Dunham
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

7.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

8.  Bilateral effects of long-term monocular timolol therapy.

Authors:  G M Kwitko; D H Shin; B H Ahn; Y J Hong
Journal:  Am J Ophthalmol       Date:  1987-12-15       Impact factor: 5.258

9.  Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication.

Authors:  Anthony J King; Alan P Rotchford
Journal:  JAMA Ophthalmol       Date:  2016-07-01       Impact factor: 7.389

10.  Contralateral intraocular pressure lowering effect of prostaglandin analogues.

Authors:  Harsha L Rao; Sirisha Senthil; Chandra S Garudadri
Journal:  Indian J Ophthalmol       Date:  2014-05       Impact factor: 1.848

View more
  2 in total

1.  Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.

Authors:  Marta Ibarz Barberá; Fátima Martínez-Galdón; Elena Caballero-Magro; Marta Rodríguez-Piñero; Pedro Tañá-Rivero
Journal:  J Glaucoma       Date:  2022-05-17       Impact factor: 2.290

2.  Phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographical atrophy.

Authors:  Thomas Hong; Andrew Chang; Ted Maddess; Jan Provis; Philip Penfold
Journal:  BMJ Open Ophthalmol       Date:  2022-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.